News
Smoking tobacco from childhood can cause premature heart damage – study

Cigarette smoking from childhood into early adulthood is associated with an increased risk of premature cardiac injury, new research has found.
This early damage to the structure and function of the heart can also significantly increase the chance of future cardiovascular (CVD) mortality in mid-life.
Andrew Agbaje, MD, MPH, PhD is lead and senior author of the study and an associate Professor of Clinical Epidemiology and Child Health at the University of Eastern Finland, Kuopio, Finland.
The researcher said: “Our goal is to provide data for policymakers, clinicians, and public health practitioners on crucial timing for preventing smoking and its early consequences in youth.
“Parents and caregivers must lead by example and government agencies should be bold to address the preventable heart disease risk by creating a smoke and nicotine-free country.
“Raising tobacco taxes is insufficient because the cost of health care due to smoking-related diseases twice exceeds tobacco tax profits.
“Why should we pay for what is killing our teenagers softly?”
Researchers from the University of Eastern Finland collaborating with the University of Bristol used the Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohort data to examine the impact of tobacco smoking during growth from childhood to young adulthood and its association with structural and functional cardiac injury.
Cardiac injury refers to damage to the heart muscle, or the myocardium, and can occur from causes such as ischemia (reduced blood flow), inflammation, trauma or chronic diseases.
Cardiac mass increase is the increase in size or weight of the heart and is often associated with cardiac hypertrophy, or the thickening of the heart muscle walls.
Both conditions can affect heart function. Adolescent smoking has been associated with vascular injury in adolescence and CVD mortality in midlife.
However, studies of cardiac structure and function in healthy children are scarce, since cardiac injury in childhood is usually due to rare clinical events.
The analysis included 1,931 young adults with complete smoking and echocardiographic measures at 24 years.
The prevalence of smoking was 0.3 per cent, 1.6 per cent, 13.6 per cent, 24 per cent, and 26.4 per cent at ages 10, 13, 15, 17, and 24 years, respectively, and 60 per cent of those who initiated smoking in childhood continued smoking at 24 years.
Researchers found that tobacco smoking from age 10 to 24 years was associated with 33 per cent to 52 per cent odds of premature structural and functional cardiac injury.
Additionally, it was associated with cardiac mass increase, even after controlling for competing risk factors.
Key study results include:
- Left ventricular (LV) hypertrophy prevalence increased from 2.8 per cent to 7.5 per cent at age 24.
- Left ventricular diastolic (LVD) dysfunction prevalence increased from 10.4 per cent to 16.9 per cent at age 24.
- Increased risk of high relative wall thickness (RWT) and high left ventricular filling pressure (LVFP).
- Increased left ventricular mass index (LVMI) in both unadjusted and adjusted models from ages 17 – 24 years.
Agbaje said: “The increase of cardiac mass structure in just a few years of smoking should convey how dangerous the consequences are for people who continue to smoke from a young age.
Emily Bucholz MD, PhD, MPH is Assistant Professor of Pediatrics at the University of Colorado School of Medicine
Bucholz said: “This study shows that teen smoking doesn’t just increase the risk of heart disease later in life – it causes early and lasting damage to heart muscle and function.
“It’s a wake-up call for prevention efforts to protect young hearts early.”
Limitations of the study include insufficient data on socio-environmental influences, including parental smoking, friends and peer smoking, or consuming alcohol.
Also, cotinine levels, which help quantify true nicotine exposure, were unavailable to analyse.
Lastly, most study participants were Caucasian, which may make findings ungeneralisable to other racial groups.
News
Gut-friendly foods may damage heart, charity warns
News
Diabetes patients face increased risk of undiagnosed heart failure

People with diabetes may have undiagnosed heart failure that could be detected by a simple screening blood test, research suggests.
The TARTAN-HF trial found that one in four patients with diabetes who had at least one other risk factor for heart failure had undiagnosed heart failure detected through screening with a blood test and ultrasound scanning of the heart.
Experts said the findings show the extent of unrecognised heart failure in people with diabetes, and how the condition can be detected using a widely available blood test called NT-proBNP, which measures how much strain the heart is under.
They suggest a heart failure screening programme for diabetics could improve diagnosis rates, lead to earlier treatment and potentially reduce the risk of hospitalisation and death.
The study, involving 700 patients, was led by the University of Glasgow in collaboration with AstraZeneca, Roche Diagnostics, Us2.ai, NHS Greater Glasgow and Clyde and NHS Lanarkshire.
Dr Kieran Docherty, clinical senior lecturer at the University of Glasgow’s School of Cardiovascular and Metabolic Health, said: “Our results from the landmark TARTAN-HF trial identified heart failure in a large proportion of people living with diabetes, emphasising the need for a heart failure screening strategy in this group of patients.
“We know that many of the symptoms and signs of heart failure are non-specific, and may go unrecognised as potentially being due to heart failure for a long time.
“The strategy used in our trial is simple and easy to implement in clinical practice, and will aid in the early identification of heart failure in people with diabetes, and facilitate the initiation of medications that we know improve outcomes in patients with heart failure.”
The study, which began more than three years ago, involved more than 700 people with diabetes from the two health board areas who had at least one other risk factor for heart failure.
They were randomly assigned either to receive heart failure screening or to continue with their usual care.
Researchers found screening uncovered a large number of previously unrecognised cases of heart failure. Around one in four, or 24.9 per cent, of those screened were found to have the condition within six months, compared with 1 per cent in the group continuing their usual care.
The study, involving patients with type 1 and type 2 diabetes, found almost all of the participants found to have heart failure had preserved ejection fraction, which can be difficult to detect without dedicated testing.
The findings of the TARTAN-HF trial were presented at the American College of Cardiology conference taking place from 28 to 30 March in New Orleans in the US.
Dr Edward Piper, medical director at AstraZeneca UK, said: “Delayed diagnosis and treatment of heart failure in people with type 2 diabetes contributes to poor long-term outcomes. TARTAN-HF demonstrates that targeted, risk-based screening can identify previously undiagnosed heart failure in approximately one in four high-risk patients with diabetes, enabling earlier intervention with guideline-directed therapy.”
Dr Christian Simon, head of global medical affairs at Roche Diagnostics, said: “We are proud to have supported the landmark TARTAN-HF trial. These findings demonstrate the transformative power of early, accessible diagnostics like the NT-proBNP blood test.
“By identifying unrecognised heart failure in people with diabetes, we enable clinicians to initiate appropriate treatments sooner, ultimately improving patient outcomes and lives.”
News
UK government announces £6.3m fund to boost men’s health

The UK has launched a £6.3m men’s health fund to back local projects aimed at helping men and boys live longer, healthier lives.
The Men’s Health Community Fund is a partnership between the Department of Health and Social Care, Movember and People’s Health Trust.
The government is contributing £3m, while the two charities are more than doubling that to take the total to £6.3m.
Grants will support community projects reaching underserved men and boys aged 16 and over, particularly in the most disadvantaged areas and at key points in their lives such as becoming a father, losing a job or retiring.
Projects could include support for new fathers, activities for men facing loneliness and social isolation, services to help young men engage with the health system, and support for men in work, out of work and moving into retirement.
The programme will bring together voluntary, community and social enterprise organisations to test new ways of reaching men who are least likely to use traditional health services.
An evaluation funded through the National Institute for Health and Care Research will assess what works and help inform future policy and delivery.
Health and social care secretary Wes Streeting said: “Too many men across the country are living shorter, less healthy lives, particularly those in our most disadvantaged communities.
“This new partnership will help men get the support they need in the places they feel most comfortable, their communities, among people they trust.
“By working with expert charities and local organisations, we can reach the men who are too often missed by traditional services and help them take better care of their mental and physical health.”
“It is a key step in delivering our first ever Men’s Health Strategy and driving forward our ambition to halve the gap in healthy life expectancy between the richest and poorest areas.”
The Men’s Health Strategy sets out plans to tackle the physical and mental health challenges men and boys face.
Men can be less likely to seek help and more likely to suffer in silence, while higher rates of smoking, drinking, gambling and drug use are damaging men’s health and affecting families, workplaces and communities.
The government is also investing £3.6m over the next three years in suicide prevention projects for middle-aged men in local communities across areas of England where men are most at risk, many of which are also among the most deprived. Suicide is one of the biggest killers of men under 50, and three-quarters of all suicides are men.
The projects will aim to break down barriers middle-aged men face in seeking support, including stigma around asking for help and a lack of awareness of what is available and how to access it.
They will be co-designed with experts and men with lived experience of mental health crises and suicidal thoughts.












